Glenmede Trust’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $699K | Sell |
7,280
-2,267
| -24% | -$232K | ﹤0.01% | 876 |
|
|
2026
Q1 | $1.04M | Buy |
9,547
+1,234
| +15% | +$118K | 0.01% | 724 |
|
|
2025
Q4 | $674K | Buy |
+8,313
| New | +$716K | ﹤0.01% | 847 |
|
|
2025
Q1 | $746K | Sell |
8,891
-147
| -2% | -$13.7K | ﹤0.01% | 780 |
|
|
2024
Q4 | $833K | Sell |
9,038
-1,474
| -14% | -$142K | ﹤0.01% | 780 |
|
|
2024
Q3 | $976K | Buy |
10,512
+136
| +1% | +$11.8K | ﹤0.01% | 725 |
|
|
2024
Q2 | $854K | Buy |
10,376
+285
| +3% | +$20.9K | ﹤0.01% | 736 |
|
|
2024
Q1 | $670K | Buy |
10,091
+1,195
| +13% | +$73.7K | ﹤0.01% | 823 |
|
|
2023
Q4 | $505K | Buy |
8,896
+235
| +3% | +$12.3K | ﹤0.01% | 887 |
|
|
2023
Q3 | $472K | Buy |
8,661
+2
| +0% | +$119 | ﹤0.01% | 860 |
|
|
2023
Q2 | $446K | Hold |
8,659
| – | – | ﹤0.01% | 864 |
|
|
2023
Q1 | $446K | Sell |
8,659
-22
| -0.3% | -$1.07K | ﹤0.01% | 869 |
|
|
2022
Q4 | $399K | Sell |
8,681
-8
| -0.1% | -$375 | ﹤0.01% | 894 |
|
|
2022
Q3 | $440K | Sell |
8,689
-478
| -5% | -$23.9K | ﹤0.01% | 841 |
|
|
2022
Q2 | $417K | Sell |
9,167
-714
| -7% | -$31.9K | ﹤0.01% | 918 |
|
|
2022
Q1 | $459K | Buy |
9,881
+1,935
| +24% | +$86.6K | ﹤0.01% | 921 |
|
|
2021
Q4 | $399K | Buy |
7,946
+108
| +1% | +$5.58K | ﹤0.01% | 984 |
|
|
2021
Q3 | $416K | Sell |
7,838
-31
| -0.4% | -$1.75K | ﹤0.01% | 947 |
|
|
2021
Q2 | $480K | Sell |
7,869
-324
| -4% | -$17.2K | ﹤0.01% | 900 |
|
|
2021
Q1 | $399K | Buy |
8,193
+73
| +0.9% | +$3.42K | ﹤0.01% | 906 |
|
|
2020
Q4 | $328K | Buy |
8,120
+446
| +6% | +$15.9K | ﹤0.01% | 940 |
|
|
2020
Q3 | $249K | Sell |
7,674
-5,606
| -42% | -$168K | ﹤0.01% | 975 |
|
|
2020
Q2 | $350K | Buy |
13,280
+11,210
| +542% | +$293K | ﹤0.01% | 862 |
|
|
2020
Q1 | $74K | Hold |
2,070
| – | – | ﹤0.01% | 1541 |
|
|
2019
Q4 | $74K | Buy |
2,070
+590
| +40% | +$20.4K | ﹤0.01% | 1541 |
|
|
2019
Q3 | $50K | Sell |
1,480
-7
| -0.5% | -$224 | ﹤0.01% | 1658 |
|
|
2019
Q2 | $41K | Buy |
1,487
+160
| +12% | +$4.45K | ﹤0.01% | 1778 |
|
|
2019
Q1 | $41K | Hold |
1,327
| – | – | ﹤0.01% | 1771 |
|
|
2018
Q4 | $31K | Buy |
+1,327
| New | +$36.2K | ﹤0.01% | 1795 |
|
|
2018
Q3 | – | Sell |
-1,100
| Closed | -$37K | – | 1654 |
|
|
2018
Q2 | $37K | Hold |
1,100
| – | – | ﹤0.01% | 1547 |
|
|
2018
Q1 | $35K | Hold |
1,100
| – | – | ﹤0.01% | 1760 |
|
|
2017
Q4 | $35K | Sell |
1,100
-6,604
| -86% | -$226K | ﹤0.01% | 1760 |
|
|
2017
Q3 | $288K | Sell |
7,704
-6,956
| -47% | -$237K | ﹤0.01% | 1096 |
|
|
2017
Q2 | $360K | Hold |
14,660
| – | – | ﹤0.01% | 1026 |
|
|
2017
Q1 | $360K | Buy |
+14,660
| New | +$344K | ﹤0.01% | 1026 |
|
Other funds holding LMAT
CCA
CAM
CCM
Glenmede Trust's LMAT Position: Q2 2026 in Review
Glenmede Trust reduced its LeMaitre Vascular (LMAT) stake by 24% in Q2 2026, selling an estimated $232K and leaving 7,280 shares worth $699K. The position accounts for ﹤0.01% of the portfolio, ranked #876.
Glenmede Trust first reported a position in LMAT in Q1 2017 and has held it in 35 quarters since. The position peaked at $1.04M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Glenmede Trust held 7,280 shares of LeMaitre Vascular worth $699K as of Q2 2026.
- Glenmede Trust sold 2,267 LeMaitre Vascular shares in Q2 2026, an estimated $232K.
- LeMaitre Vascular made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #876 holding.
- Glenmede Trust first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 35 quarters since.
- Glenmede Trust's LeMaitre Vascular position peaked at $1.04M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.